Longevity Startups

Spindle is a health company focused on muscle strength and age-related muscle loss (sarcopenia), presenting health information on muscle metabolism, mitochondrial function, and gut health. It appears to develop a consumer health product supported by scientific research and expert advisors.

1 investor

TMRW is a health membership service focused on helping members live longer and healthier through integrative, clinician-led care. It combines medical practitioners, health coaches, and bioinformatics to support personal health and longevity.

1 investor

Stayble Therapeutics is a clinical-stage pharmaceutical company developing an injection-based treatment for disc herniation. The company is currently conducting phase 1b clinical trials for its therapeutic candidate.

1 investor

StemBioSys develops cell culture technology, including the patented CELLvo Matrix that replicates the body's physiological microenvironment to expand mesenchymal stem cells and specialty cells while preserving their stem-like properties. It supplies cells and cell expansion tools for stem cell research and regenerative medicine applications.

1 investor

Sunday Health is a preventive cognitive neurology clinic that delivers dementia prevention, detection, and treatment through virtual and in-person care, combining digital cognitive assessments and blood-based biomarker testing to enable early intervention. The clinic serves older adults and those concerned about cognitive decline, emphasizing proactive, personalized guidance based on the latest neuroscience research.

1 investor

Sunny Within makes clean liposomal dietary supplements formulated with organic avocado oil for longevity, immune support, and cellular health. Its products use liposomal delivery to improve nutrient absorption, sold directly to consumers.

1 investor

Symbiont Health builds a fall-detection system that uses a mesh network of Wi-Fi routers to detect falls without pendants, wearables, or body sensors, and shares vital signs and medication information with caregivers. Its AI-based analytics provide patient behavior statistics for use in elderly and memory care communities.

1 investor

SYNERGY HomeCare is a home care franchise network providing non-medical in-home care services including senior care, specialized care for disabilities, memory care, and hospital-to-home transitional services across the United States. The company operates over 210 franchises in more than 450 locations and employs direct caregivers who receive background checks and training.

1 investor

TAG Therapeutics develops TELOBLOCK, an antisense nucleotide therapy that inhibits the DNA damage response at short or damaged telomeres to reduce cellular senescence, targeting telomere biology disorders and age-related diseases such as idiopathic pulmonary fibrosis and bone marrow failure. The company also explores ex-vivo applications to improve immune cell fitness for bone marrow transplantation and cancer immunotherapies.

1 investor

TAZ develops anti-aging products and drug discovery research focused on cellular senescence removal and longevity science. The company provides biomarker testing services, contract product development, and drug candidates to extend healthspan in an aging society.

1 investor

Teal (Tealomics) operates a proteomics and multi-omic analytics platform that maps molecular changes in human biology to support precision medicine research, with a focus on the biology of aging and chronic disease. It partners with life science organizations to accelerate drug discovery.

1 investor

TECregen develops regenerative biologic therapies aimed at thymus regeneration and restoring immune function, using ligand engineering, targeted delivery, and functional screening. Its therapeutics target immune decline, cancer, and inflammatory disease.

1 investor

Telomere Therapeutics is a gene therapy company developing treatments that repair telomeres to address organ fibrosis and telomere-dysfunction syndromes. Its lead program is an AAV-based therapy for idiopathic pulmonary fibrosis (IPF).

1 investor

Tertianum operates senior living residences and care homes in Switzerland, offering apartments and assisted living for elderly residents. It focuses on providing a supportive living environment for seniors making the transition to age-appropriate housing.

1 investor

The Well Estate develops wellness-focused hospitality concepts, partnering with hotels and hospitality operators to add wellness-oriented guest experiences and new revenue streams. The company positions itself around extending human healthspan through fitness and lifestyle offerings.

1 investor

The Healthy is a digital media publication that translates longevity and aging science into accessible articles, expert-vetted health information, and patient stories for proactive readers in the United States. Its content is produced by staff editors and journalists and reviewed by licensed medical professionals.

1 investor

Thunder Biotech is a cancer immunotherapy company developing MOTO-CAR treatments, which genetically engineer a patient's own macrophages into chimeric antigen receptor cells that target biomarkers on tumor cells to attack solid tumors. It focuses on immunotherapy for cancer patients with solid tumors.

1 investor

A media platform that publishes editorial content about Japan, including profiles of individuals and craftspeople, travel guides to regional destinations, and cultural explorations of Japanese traditions and lifestyle.

1 investor

Twinn Health provides preventive whole-body MRI infrastructure, offering AI-structured reporting and longitudinal health data for imaging providers and wellness clinics, plus expert MRI interpretation support for individuals. Originating from research at Imperial College London, it focuses on early disease detection in emerging longevity markets across the UK and the Middle East.

1 investor

Unleash Immuno Oncolytics is an immuno-oncology company developing armed, conditionally replicating oncolytic viruses that target both tumor cells and the tumor-associated stroma to trigger a systemic anti-cancer immune response. Its lead product uses virally produced cytokines to disrupt tumor architecture and treat cancers, including metastatic disease.

1 investor

Vascugen develops an induced-pluripotent stem cell (iPSC)-derived vasculogenic cell therapy intended to form new blood vessels and restore microvascular circulation in oxygen-starved tissues. It targets diabetic and arterial disease patients at high risk of limb amputation, and handles development from R&D through cGMP manufacturing.

1 investor

Vero BioScience develops a blood-based proteomic test that measures organ-specific protein signatures to assess the biological age of individual organs and detect early signs of age-related disease. The company targets individuals seeking predictive health insights and preventive medicine interventions based on technology developed at Stanford.

1 investor

Viking Therapeutics is a clinical-stage biopharmaceutical company developing therapies in areas such as metabolic and endocrine disorders. This page presents its board of directors.

1 investor

Vitali Health is a healthcare company focused on proactively identifying seniors who need mental health support and connecting them with specialists in aging, aiming to make mental health care a normal part of aging.

1 investor